(Q73218712)
Statements
High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group (English)
G Schellong
R Pötter
J Brämswig
W Wagner
F J Prott
W Dörffel
D Körholz
G Mann
B Rath
A Reiter
G Weissbach
M Riepenhausen
M Thiemann